This is not a close comparison on clinical evidence
This discovery relates to the simultaneous use of the peptide with at least one of the umbilical cord/placental blood, plasma, mesenchymal stem cells (MSCs), and/or mono-nucleated cells (MNCs) in the treatment of ocular diseases, including dry eye, inflammation, oxidative stress, and eye injury)
Another patient developed a severe facial rash days after a shot and cleared after stopping injections and receiving topical care
BPC-157 is not recommended for anyone who is pregnant, may become pregnant, or nursing, nor is it endorsed to be used by children
NAD and NMN : biologically interesting, clinically unproven
Cheap product can mean low quality, which puts patients and your license at risk